MG
SGMO

Michael Gelband’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Michael Gelband’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-41,322
Closed -$42K – 1945
2024
Q4 		$42K Buy
+41,322
New +$75.5K ﹤0.01% 1430
2023
Q4 		– Sell
-1,890,425
Closed -$1.13M – 1991
2023
Q3 		$1.13M Sell
1,890,425
-193,208
-9% -$207K 0.01% 918
2023
Q2 		$2.71M Buy
2,083,633
+774,310
+59% +$1.06M 0.02% 690
2023
Q1 		$2.3M Buy
1,309,323
+1,089,804
+496% +$3.11M 0.02% 816
2022
Q4 		$689K Sell
219,519
-133,211
-38% -$517K 0.01% 1073
2022
Q3 		$1.73M Buy
352,730
+39,288
+13% +$202K 0.02% 865
2022
Q2 		$1.3M Buy
+313,442
New +$1.36M 0.02% 959
2022
Q1 		– Sell
-72,815
Closed -$546K – 2628
2021
Q4 		$546K Buy
72,815
+9,937
+16% +$86.3K 0.01% 1352
2021
Q3 		$567K Sell
62,878
-113
-0.2% -$1.12K 0.01% 1304
2021
Q2 		$754K Buy
+62,991
New +$713K 0.01% 1143
2021
Q1 		– Sell
-20,611
Closed -$322K – 2550
2020
Q4 		$322K Sell
20,611
-30,049
-59% -$352K ﹤0.01% 1510
2020
Q3 		$479K Buy
+50,660
New +$548K 0.01% 1044
2020
Q1 		– Sell
-10,039
Closed -$84K – 1585
2019
Q4 		$84K Sell
10,039
-6,431
-39% -$59.1K ﹤0.01% 1439
2019
Q3 		$149K Buy
16,470
+5,470
+50% +$61.4K 0.01% 1185
2019
Q2 		$118K Buy
+11,000
New +$117K ﹤0.01% 1008

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Michael Gelband's SGMO Position: Q1 2025 in Review

Michael Gelband sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2025, closing a stake of 41,322 shares — an estimated $42K sold.

Michael Gelband first reported a position in SGMO in Q2 2019 and held it in 15 quarters. The position peaked at $2.71M in Q2 2023. 122 funds tracked by Wall St. Rank hold SGMO as of Q1 2025.

  • Michael Gelband reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2025 after selling out during the quarter.
  • Michael Gelband sold 41,322 SANGAMO THERAPEUTICS INC shares in Q1 2025, an estimated $42K.
  • Michael Gelband first reported a position in SANGAMO THERAPEUTICS INC in Q2 2019 and held it in 15 quarters.
  • Michael Gelband's SANGAMO THERAPEUTICS INC position peaked at $2.71M in Q2 2023.
  • 122 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2025.

Based on ExodusPoint Capital Management's 13F filing for Q1 2025, filed 14 May 2025.